Preserved endothelial function in patients with severe hypertriglyceridemia and low functional lipoprotein lipase activity

Journal of the American College of Cardiology

Volumn 29, Issue 5, 1997, Pages 964-968

  Chowienczyk, Philip J ^a   Watts, Gerald F ^b   Wierzbicki, Anthony S ^a   Cockcroft, John R ^a   Brett, Sally E ^a   Ritter, James M ^a  

^a KING'S COLLEGE LONDON   (United Kingdom)

^b UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLCHOLINE; ARGININE; LIPOPROTEIN LIPASE; LOW DENSITY LIPOPROTEIN CHOLESTEROL; NITRIC OXIDE; NITROPRUSSIDE SODIUM;

ADULT; ARTICLE; CLINICAL ARTICLE; ENDOTHELIUM; ENZYME ACTIVITY; FEMALE; FOREARM BLOOD FLOW; HUMAN; HYPERTRIGLYCERIDEMIA; MALE; PRIORITY JOURNAL; VASODILATATION;

ACETYLCHOLINE; ADULT; ANTIHYPERTENSIVE AGENTS; ENDOTHELIUM, VASCULAR; FEMALE; FOREARM; HUMANS; HYPERTRIGLYCERIDEMIA; LIPOPROTEIN LIPASE; MALE; MIDDLE AGED; NITROPRUSSIDE; REGIONAL BLOOD FLOW;

EID: 0030977706     PISSN: 07351097     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0735-1097(97)00033-8     Document Type: Article

References (41)

1. Bossaller C, Habib GB, Yamamoto H, Williams C, Wells S, Henry PD. Impaired muscarinic endothelium-dependent relaxation and cyclic guanosine 5′-monophosphate formation in atherosclerotic human coronary artery and rabbit aorta. J Clin Invest. 79:1987;170-174.
2. Ludmer PL, Selwyn AP, Shook TL, et al. Paradoxical vasoconstriction induced by acetylcholine in atherosclerotic coronary arteries. N Engl J Med. 315:1986;1046-1051.
3. Zeiher AM, Drexler H, Wollschläger H, Just H. Modulation of coronary vasomotor tone in humans Progressive endothelial dysfunction with different early stages of coronary atherosclerosis . Circulation. 83:1991;391-401.
4. Chowienczyk PJ, Watts GF, Cockcroft JR, Ritter JM. Impaired endothelium-dependent vasodilation of forearm resistance vessels in hypercholesterolaemia. Lancet. 340:1992;1430-1432.
5. Creager MA, Gallagher SJ, Girerd XJ, Coleman SM, Dzau VJ, Cooke JP. L-Arginine improves endothelium-dependent vasodilation in hypercholesterolaemic humans. J Clin Invest. 90:1992;1248-1253.
6. Drexler H, Zeiher AM, Meinzer K, Just H. Correction of endothelial dysfunction in the coronary microcirculation of hypercholesterolaemic patients by L-arginine. Lancet. 338:1991;1546-1550.
7. Radomski MW, Palmer RMJ, Moncada S. Endogenous nitric oxide inhibits human platelet adhesion to vascular endothelium. Lancet. 2:1987;1057-1058.
8. Radomski MW, Palmer RMJ, Moncada S. An L-arginine-nitric oxide pathway present in human platelets regulates aggregation. Proc Natl Acad Sci USA. 87:1990;5193-5197.
9. Garg UC, Hassid A. Nitric oxide-generating vasodilators and 8-bromo-cyclic guanosine monophosphate inhibit mitogenesis and proliferation of cultured rat smooth muscle cells. J Clin Invest. 83:1989;1774-1777.
10. Kubes P, Suzuki M, Granger DN. Nitric oxide an endogenous modulator of leukocyte adhesion . Proc Natl Acad Sci USA. 88:1991;4651-4655.
11. Jessup W, Dean RT. Autoinhibition of murine macrophage-mediated oxidation of low-density lipoprotein by nitric oxide synthesis. Atherosclerosis. 101:1993;145-155.
12. 2 does not contribute to impaired endothelium-dependent relaxation . Arterioscler Thromb. 14:1994;746-752.
13. Cayatte AJ, Palacino JJ, Horten K, Cohen RA. Chronic inhibition of nitric oxide production accelerates neointimal formation and impairs endothelial function in hypercholesterolemic rabbits. Arterioscler Thromb. 14:1994;753-759.
14. Cooke JP, Singer AH, Tsao P, Zera P, Rowan RA, Billingham ME. Antiatherogenic effects of L-arginine in the hypercholesterolaemic rabbit. J Clin Invest. 90:1992;1168-1172.
15. Jacobs M, Plane F, Bruckdorfer KR. Native and oxidized low-density lipoproteins have different inhibitory effects on endothelium-derived relaxing factor in rabbit aorta. Br J Pharmacol. 100:1990;21-26.
16. Takahashi M, Yui Y, Yasumoto H, et al. Lipoproteins are inhibitors of endothelium-dependent relaxation of rabbit aorta. Am J Physiol. 258:1990;H1-8.
17. McVeigh GE, Brennan GM, Johnston GD, et al. Impaired endothelium-dependent and independent vasodilation in patients with type 2 (non-insulin-dependent) diabetes mellitus. Diabetologia. 35:1992;771-776.
18. Panza JA, Quyyumi AA, Brush JE, Epstein SE. Abnormal endothelium-dependent vascular relaxation in patients with essential hypertension. N Engl J Med. 323:1990;22-27.
19. Linder L, Kiowski W, Bühler FR, Lüscher TF. Indirect evidence for release of endothelium-derived relaxing factor in human forearm circulation in vivo blunted response in essential hypertension . Circulation. 81:1990;1762-1767.
20. Cockcroft JR, Chowienczyk PJ, Benjamin N, Ritter JM. Preserved endothelium-dependent vasodilation in patients with essential hypertension. N Engl J Med. 330:1994;1036-1040.
21. Dejager S, Brucker E, Chapman MJ. Dense LDL sub-species with diminished oxidative resistance predominate in combined hyperlipidaemia. J Lipid Res. 34:1993;295-308.
22. Tribble DL, Holl LG, Wood PD, Krauss RM. Variations in oxidative susceptibility among six low density lipoprotein subfractions of differing density and particle size. Atherosclerosis. 93:1992;189-199.
23. Pacy PJH, Mitropoulos KA, Venkatesan S, Watts GF, Reeves BEA, Halliday D. Metabolism of apolipoprotein B-100 and of triglyceride-rich lipoprotein particles in the absence of functional lipoprotein lipase. Atherosclerosis. 103:1993;231-243.
24. Demant T, Gaw A, Watts GF, et al. Metabolism of apoB-100-containing lipoproteins in familial hyperchylomicronaemia. J Lipid Res. 34:1993;147-156.
25. Whitney RJ. The measurement of volume changes in human limbs. J Physiol (Lond). 121:1953;1-27.
26. Hokanson DE, Sumner DS, Strandness DE Jr. An electrically calibrated plethysmograph for direct measurement of limb blood flow. IEEE Trans Biomed Eng. 22:1975;25-29.
27. Chowienczyk PJ, Watts GF, Cockcroft JR, Brett SE, Ritter JM. Sex differences in endothelial function in normal and hypercholesterolaemic subjects. Lancet. 344:1994;305-306.
28. G-monomethyl-L-arginine resistant actions of acetylcholine in human forearm vasculature. Clin Sci. 88:1995;111-117.
29. Chowienczyk PJ, Cockcroft JR, Ritter JM. Blood flow responses to intra-arterial acetylcholine in man effects of basal flow and conduit vessel length . Clin Sci. 87:1994;45-51.
30. Stampfer MJ, Sacks FM, Salvini S, Willet WC, Hennekens CH. A prospective study of cholesterol, apolipoproteins, and the risk of myocardial infarction. N Engl J Med. 325:1991;373-381.
31. Castelli WP. The triglyceride issue a view from Framingham . Am Heart J. 112:1986;432-437.
32. Austin MA. Epidemiological association between hypertriglyceridaemia and coronary heart disease. Semin Thromb Hemost. 14:1988;137-142.
33. Criqui MH, Heiss MPH, Cohn RC, et al. Plasma triglyceride level and mortality from coronary heart disease. N Engl J Med. 328:1993;1220-1225.
34. Kaplan NM. The deadly quartet upper body obesity, glucose intolerance, hypertriglyceridaemia and hypertension . Arch Intern Med. 149:1989;1514-1520.
35. Ross R. The pathogenesis of atherosclerosis a perspective for the 1990s . Nature. 362:1993;801-809.
36. Casino PR, Kilcoyne CM, Quyyumi AA, Hoeg JM, Panza JA. The role of nitric oxide in endothelium-dependent vasodilation of hypercholesterolaemic patients. Circulation. 88:1993;2541-2547.
37. Lüscher TF. The endothelium and cardiovascular disease - a complex relation. N Engl J Med. 330:1994;1081-1083.
38. Austin MA, Breslow JL, Hennekens CH, Buring JE, Willet WC, Krauss RM. Low-density lipoprotein subclass patterns and risk of myocardial infarction. JAMA. 260:1988;1917-1921.
39. Durrington PN, MacIver JE, Holdsworth G, Galton DJ. Severe hypertriglyceridaemia associated with pancytopenia and lipoprotein lipase deficiency. Ann Intern Med. 94:1981;211-217.
40. Mitropoulos KA, Miller GJ, Watts GF, Durrington PN. Lipolysis of triglyceride-rich lipoproteins activates coagulant factor XII a study in familial lipoprotein-lipase deficiency . Atherosclerosis. 95:1992;119-125.
41. Zeiher AM, Schächinger V, Hohnloser SH, Saurbier B, Just H. Coronary atherosclerotic wall thickening and vascular reactivity in humans. Circulation. 89:1994;2525-2532.